Stilla Technologies
Villejuif
About Stilla Technologies
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible digital PCR (dPCR) solution: the Naica System. Taking advantage of cutting-edge microfluidic innovations, Stilla aims to make dPCR a lab commodity to all Life Sciences areas: research, therapeutics, and all the “omics”.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $101.7M
- Funding stage: M&A
- Last round: Series C (Feb 2024)
- Website: stillatechnologies.com
- Phone: (+33) 09 82 29 50 50
Industries & Categories
Biotechnology, Consumer Research, Genetics, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/stilla-technologies-27713 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.